The investment made through Accenture Ventures will help expand access to virtual diagnostic health testing
Accenture has made an undisclosed investment in ixlayer, a technology-based solutions provider for diagnostic testing.
The investment made through Accenture Ventures will help the Ireland-based consulting and professional services firm to expand access to virtual diagnostic health testing.
Ixlayer’s telehealth platform enables players across the healthcare ecosystem to provide health testing in a virtual environment in a convenient and scalable manner.
The platform is said to simplify the complex technical, user experience, security, and regulatory components of virtual testing.
By connecting the health testing ecosystem of services, Ixlayer’s proprietary technology is said to facilitate the rapid launch of testing programs while driving engagement by letting patients access lab testing from the comfort of their homes.
According to Accenture, ixlayer’s solution can be deployed within weeks in contrast to several enterprise-grade solutions that can take months to implement.
Ixlayer CEO Pouria Sanae said: “Accenture’s investment in ixlayer will bolster our ability to deliver scalable, flexible solutions that connect consumers, providers and labs for more convenient and streamlined diagnostic testing.
“We look forward to working with Accenture to help clients around the world meet the ever-growing demand for virtual healthcare services.”
Ixlayer’s solution can also be added to existing patient engagement platforms and patient portals for facilitating health and wellness lab testing in real time.
The diagnostic health testing start-up is the latest addition to the investment portfolio of Accenture Ventures, which is engaged in investing in firms that develop or apply disruptive enterprise technologies.
Accenture Ventures managing director Tom Lounibos said: “Accenture Ventures’ investment in ixlayer reflects our mission to support companies that are poised to transform their industries and meet our clients’ most pressing needs.
“ixlayer is leading the charge toward connecting the varied, complex components of the healthcare system under one umbrella to provide simplified, end-to-end services. We’re excited to collaborate with them on this enormous opportunity.”
Earlier this year, ixlayer had raised $75m in a Series A funding round led by General Catalyst.